Intermediate acting insulin for type 2 diabetes.

Intermediate acting insulin for type 2 diabetes.

Bibliographic Details
Main Authors:	Turner, R, Holman, R
Format:	Journal article
Language:	English
Published:	1985

Similar Items

Insulin therapy in type II diabetes.
by: Holman, R, et al.
Published: (1995)

Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement.
by: Holman, R, et al.
Published: (1987)

Insulin Regimens in Type 2 Diabetes REPLY
by: Holman, R, et al.
Published: (2010)

TWICE-DAILY SUBCUTANEOUS HUMAN PROINSULIN PROVIDES A SATISFACTORY BASAL INSULIN SUPPLEMENT IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS
by: Holman, R, et al.
Published: (1987)

UKPDS: Plasma leptin, obesity and plasma insulin in type 2 diabetic subjects
by: Widjaja, A, et al.
Published: (1996)

UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
by: Cull, C, et al.
Published: (1995)

UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects.
by: Widjaja, A, et al.
Published: (1997)

Different insulin regimens for type 2 diabetes mellitus
by: Farmer, A, et al.
Published: (2006)

Addition of insulin to oral therapy in type 2 diabetes - Reply
by: Holman, R, et al.
Published: (2008)

Insulin rather than glucose homoeostasis in the pathophysiology of diabetes.
by: Turner, R, et al.
Published: (1976)

Relative contributions of insulin deficiency and insulin resistance in maturity-onset diabetes.
by: Turner, R, et al.
Published: (1982)

TREATMENT OF TYPE-4 HYPERTRIGLYCERIDEMIA WITH INSULIN
by: Turner, R, et al.
Published: (1977)

NASAL INSULIN OUTPATIENT STUDY IN TYPE-I DIABETES
by: Holman, R, et al.
Published: (1992)

Maintenance of basal plasma glucose and insulin concentrations in maturity-onset diabetes.
by: Holman, R, et al.
Published: (1979)

Comparative efficacy and complications of long-acting and intermediate-acting insulin regimens for adults with type 1 diabetes: an individual patient data network meta-analysis
by: Dimitris Mavridis, et al.
Published: (2022-11-01)

TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES OF EARLY ONSET - A DISTINCT CLINICAL AND GENETIC SYNDROME
by: Orahilly, S, et al.
Published: (1986)

METFORMIN IN THE MANAGEMENT OF TYPE-2 DIABETES - REPLY
by: Holman, R, et al.
Published: (1989)

betacell function during insulin or chlorpropamide treatment of maturity-onset diabetes mellitus.
by: Turner, R, et al.
Published: (1978)

UKPDS 18: Estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy
by: Eeley, E, et al.
Published: (1996)

TIMING OF NASAL INSULIN DELIVERY IN TYPE-I DIABETES
by: Holman, R, et al.
Published: (1993)

UKPDS 18: estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy. UK Prospective Diabetes Study Group.
by: Eeley, E, et al.
Published: (1996)

Differences in insulin treatment satisfaction following randomized addition of biphasic, prandial or basal insulin to oral therapy in type 2 diabetes.
by: Farmer, A, et al.
Published: (2011)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
by: Turner, R, et al.
Published: (1999)

Effects of Ultra-Long-Acting Insulin Compared to Long-Acting Insulin on Diabetic Ketoacidosis Incidence in Type 1 Diabetes Mellitus Patients
by: Alsofiani WA, et al.
Published: (2022-03-01)

Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations.
by: Turner, R, et al.
Published: (1979)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus - Progressive requirement for multiple therapies (UKPDS 49)
by: Turner, R, et al.
Published: (1999)

The effect of nateglinide stimulated insulin secretion on post challenge glucose and lipid metabolism in Type 2 diabetes
by: Mohanlal, N, et al.
Published: (2002)

Three-year efficacy of complex insulin regimens in type 2 diabetes.
by: Holman, R, et al.
Published: (2009)

Risk factors for stroke in non-insulin dependent diabetic subjects.
by: Millns, H, et al.
Published: (1997)

Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses.
by: Lasserson, D, et al.
Published: (2009)

Insulin infusion pump.
by: Holman, R, et al.
Published: (1981)

ATTEMPTED BETA-CELL SALVAGE BY A REGULAR MEAL INSULIN INFUSION REGIME IN NEW SEVERE KETOTIC DIABETICS
by: Turner, R, et al.
Published: (1977)

COMPARISON OF TREATMENT OF MILD DIABETES WITH A BASAL INSULIN SUPPLEMENT OR SULFONYLUREA
by: Holman, R, et al.
Published: (1977)

UK PROSPECTIVE DIABETES STUDY (UKPDS) .10. URINARY ALBUMIN EXCRETION OVER 3 YEARS IN DIET-TREATED TYPE-2, (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS, AND ASSOCIATION WITH HYPERTENSION, HYPERGLYCEMIA AND HYPERTRIGLYCERIDEMIA
by: Cull, C, et al.
Published: (1993)

Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.
by: Holman, R, et al.
Published: (2007)

Induced basal normoglycemia and altered platelet aggregation in non-insulin-dependent diabetes.
by: Evans, R, et al.
Published: (1982)

Beta-cell function improved by supplementing basal insulin secretion in mild diabetes.
by: Turner, R, et al.
Published: (1976)

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes
by: Turner, R, et al.
Published: (1997)

BETA-CELL RECOVERY WITH A REGULAR MEAL-INSULIN INFUSION REGIME IN NEW, SEVERE, KETOTIC DIABETICS
by: Turner, R, et al.
Published: (1977)

Efficacy over six years of sulphonylurea plus insulin therapy in type 2 diabetic patients in the UKPDS
by: Cull, C, et al.
Published: (2000)